Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

NCT00002482 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: antibody therapy
BIOLOGICAL: biological therapy
BIOLOGICAL: muromonab-CD3
DRUG: cyclophosphamide

Sponsor

St. Vincent Medical Center - Los Angeles